当前位置:
X-MOL 学术
›
Nat. Rev. Neurosci.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Gene therapy for chronic pain: emerging opportunities in target-rich peripheral nociceptors
Nature Reviews Neuroscience ( IF 28.7 ) Pub Date : 2023-01-19 , DOI: 10.1038/s41583-022-00673-7 Saak V Ovsepian 1 , Stephen G Waxman 2, 3, 4
中文翻译:
慢性疼痛的基因治疗:目标丰富的外周伤害感受器的新机遇
更新日期:2023-01-20
Nature Reviews Neuroscience ( IF 28.7 ) Pub Date : 2023-01-19 , DOI: 10.1038/s41583-022-00673-7 Saak V Ovsepian 1 , Stephen G Waxman 2, 3, 4
Affiliation
With sweeping advances in precision delivery systems and manipulation of the genomes and transcriptomes of various cell types, medical biotechnology offers unprecedented selectivity for and control of a wide variety of biological processes, forging new opportunities for therapeutic interventions. This perspective summarizes state-of-the-art gene therapies enabled by recent innovations, with an emphasis on the expanding universe of molecular targets that govern the activity and function of primary sensory neurons and which might be exploited to effectively treat chronic pain.
中文翻译:
慢性疼痛的基因治疗:目标丰富的外周伤害感受器的新机遇
随着精确递送系统和各种细胞类型的基因组和转录组操作的全面进步,医学生物技术为各种生物过程提供了前所未有的选择性和控制,为治疗干预创造了新的机会。这一观点总结了最近创新所带来的最先进的基因疗法,重点是不断扩大的分子靶标范围,这些靶标控制着初级感觉神经元的活动和功能,并可能被用来有效治疗慢性疼痛。